Article Text

Download PDFPDF
Effect of beta propiolactone on specific antibody measurements by ELISA.
  1. A E Agbarakwe,
  2. S A Misbah,
  3. H Griffiths,
  4. H M Chapel
  1. Department of Immunology, John Radcliffe Hospital, Oxford.


    Serum samples from 30 HIV seronegative patients were treated with beta propiolactone (BPL) to determine whether BPL interfaces with ELISA for specific antibodies against protein and carbohydrate antigens. BPL had no discernible effect on specific antibody measurements by ELISA. With the measuring need for specific antibody measurements in the management of HIV seropositive patients, it is reassuring that this laboratory safety measure does not impair the reliability of results.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles